Deschatelets Pascal's Form 4 filing
Apellis Pharmaceuticals, Inc. (APLS) · filed Jul 12, 2022
- Accession no.
- 0001127602-22-019227
- Filed
- Jul 12, 2022
- Trade date
- Jul 8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $575.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Deschatelets PascalCIK 0001657720 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | MOption exerciseAcquired | +12,000 | $2.67 | +$32,040 | 943,280 | Direct | |
| Jul 8, 2022 | Common Stock | MOption exerciseAcquired | +6,500 | $2.67 | +$17,355 | 949,780 | Direct | |
| Jul 8, 2022 | Common Stock | SSaleDisposed | −12,000 | $47.95 | −$575,400 | 937,780 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 301,494 | Direct | |
| Jul 8, 2022 | Common Stock | MOption exerciseDisposed | −6,500 | $0.00 | $0 | 294,994 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.